Literature DB >> 15082584

Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia.

J Hammer1, G D Eslick, S C Howell, E Altiparmak, N J Talley.   

Abstract

OBJECTIVE: The diagnostic value of the addition of alarm symptoms in distinguishing functional from organic gastrointestinal disease remains uncertain. We aimed to establish the value of alarm features in differentiating between organic disease and irritable bowel syndrome (IBS) and functional dyspepsia (FD).
METHODS: A total of 568 consecutive patients (63% female; mean age 44.7 years) completed a detailed symptom questionnaire and then received a complete diagnostic workup, as required. Questionnaire data were collected prospectively and audited retrospectively; the treating physician was blinded to the results of the questionnaires. Patients were coded and allocated to the following diagnostic groups: IBS, FD, organic diseases of the upper gastrointestinal tract, or organic diseases of the lower gastrointestinal tract. Logistic regression was used to identify the best subset of symptoms that discriminated organic disease from functional illness. Separate models compared IBS (n = 214) with diseases of the lower gastrointestinal tract (n = 66), and FD (n = 70) with diseases of the upper gastrointestinal tract (n = 250).
RESULTS: Age (50 years at symptom onset: odds ratio (OR) 2.65 (95% confidence interval 1.4-5.0); p = 0.002) and blood on the toilet paper (OR 2.7 (1.4-5.1);p = 0.002) emerged as alarm features that discriminated IBS from lower gastrointestinal illness. A diagnosis of IBS was typically associated with female sex (OR2.5 (1.3-4.6); p = 0.004), pain on six or more occasions in the previous year (OR 5.0 (2.2-11.1); p<0.001), pain that radiated outside of the abdomen (OR 2.9 (1.4-6.3); p = 0.006), and pain associated with looser bowel motions (OR 2.1 (1.1-4.2); p = 0.03). A model incorporating three Manning criteria and alarm features yielded a correct diagnosis of IBS in 96% and a correct diagnosis of organic disease in 52% of cases. Alarm features did not discriminate FD from upper gastrointestinal disease. Patients with FD were significantly more likely to report upper abdominal pain (OR 3.7 (1.7-8.3); p = 0.002) and significantly less likely to report aspirin use (OR 0.26 (0.1-0.6); p = 0.001). The predictive value of symptoms in diagnosing FD was only 17%.
CONCLUSIONS: Symptoms plus alarm features have a high predictive value for diagnosing IBS but the predictive value for a diagnosis of FD remains poor. Current criteria for the diagnosis of IBS should incorporate relevant alarm features to improve the diagnostic yield.

Entities:  

Mesh:

Year:  2004        PMID: 15082584      PMCID: PMC1774043          DOI: 10.1136/gut.2003.021857

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome.

Authors:  S J Vanner; W T Depew; W G Paterson; L R DaCosta; A G Groll; J B Simon; M Djurfeldt
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

Review 2.  Functional bowel disorders and functional abdominal pain.

Authors:  W G Thompson; G F Longstreth; D A Drossman; K W Heaton; E J Irvine; S A Müller-Lissner
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 3.  Functional gastroduodenal disorders.

Authors:  N J Talley; V Stanghellini; R C Heading; K L Koch; J R Malagelada; G N Tytgat
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

4.  Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55?

Authors:  D Gillen; K E McColl
Journal:  Am J Gastroenterol       Date:  1999-01       Impact factor: 10.864

Review 5.  Diagnostic criteria for the irritable bowel syndrome.

Authors:  J Hammer; N J Talley
Journal:  Am J Med       Date:  1999-11-08       Impact factor: 4.965

6.  Irritable bowel syndrome: a multibillion-dollar problem.

Authors:  G F Longstreth
Journal:  Gastroenterology       Date:  1995-12       Impact factor: 22.682

7.  Predicting endoscopic diagnosis in the dyspeptic patient. The value of predictive score models.

Authors:  P Bytzer; J M Hansen; O B Schaffalitzky de Muckadell; A Malchow-Møller
Journal:  Scand J Gastroenterol       Date:  1997-02       Impact factor: 2.423

8.  Kruis scoring system and Manning's criteria in diagnosis of irritable bowel syndrome: is it better to use combined?

Authors:  U B Doğan; S Unal
Journal:  Acta Gastroenterol Belg       Date:  1996 Oct-Dec       Impact factor: 1.316

9.  Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia.

Authors:  J Christie; N A Shepherd; B W Codling; R M Valori
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

10.  Self-reported rectal bleeding in a United States community: prevalence, risk factors, and health care seeking.

Authors:  N J Talley; M Jones
Journal:  Am J Gastroenterol       Date:  1998-11       Impact factor: 10.864

View more
  48 in total

Review 1.  Bringing science to the art of diagnosis.

Authors:  P Moayyedi
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 2.  Diagnosis and management of IBS.

Authors:  Sarah Khan; Lin Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 46.802

3.  Evaluation and management of dyspepsia.

Authors:  R Christopher Harmon; David A Peura
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

4.  Commentary: Controversies in NICE guidance on irritable bowel syndrome.

Authors:  Nicholas J Talley
Journal:  BMJ       Date:  2008-03-08

Review 5.  Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.

Authors:  P Paré; Ronald Bridges; Malcolm C Champion; Subhas C Ganguli; James R Gray; E Jan Irvine; Victor Plourde; Pierre Poitras; Geoffrey K Turnbull; Paul Moayyedi; Nigel Flook; Stephen M Collins
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

6.  Evidence-based clinical practice guidelines for functional dyspepsia.

Authors:  Hiroto Miwa; Motoyasu Kusano; Tomiyasu Arisawa; Tadayuki Oshima; Mototsugu Kato; Takashi Joh; Hidekazu Suzuki; Kazunari Tominaga; Koji Nakada; Akihito Nagahara; Seiji Futagami; Noriaki Manabe; Akio Inui; Ken Haruma; Kazuhide Higuchi; Koji Yakabi; Michio Hongo; Naomi Uemura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2015-01-14       Impact factor: 7.527

Review 7.  Irritable bowel syndrome.

Authors:  N J Talley
Journal:  Intern Med J       Date:  2006-11       Impact factor: 2.048

8.  Adequate relief in a treatment trial with IBS patients: a prospective assessment.

Authors:  Maria C F Passos; Anthony J Lembo; Lisa A Conboy; Ted J Kaptchuk; John M Kelly; Mary T Quilty; Catherine E Kerr; Eric E Jacobson; Rong Hu; Elizabeth Friedlander; Douglas A Drossman
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

9.  The current prevalence of irritable bowel syndrome in Asia.

Authors:  Full-Young Chang; Ching-Liang Lu; Tseng-Shing Chen
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

10.  Diagnostic yield of oesophagogastroduodenoscopy in children with abdominal pain.

Authors:  K Thakkar; L Chen; N Tatevian; R J Shulman; A McDuffie; M Tsou; M A Gilger; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2009-07-02       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.